Startups
TOLREMO therapeutics

TOLREMO therapeutics

https://tolremo.com

Developer of small molecules to treat novel drug resistance pathways in cancer therapy.

Summary

Seedtable Score
  • 37
Locations
Company Size
  • 1 to 10 employees
Last Stage Round
  • Series A
Industry

Total funding Amount

$37M

Fundraising History

  • Sep 20 '23 Series A
    $20M
  • Jun 20 '20 Series A
    $5.1M
  • Sep 24 '18 Series A
    $9.9M
  • Sep 19 '17 Seed
    $2.6M

Investors

  • BioMedPartners
    Series A
  • Altos Ventures
    Series A
  • Redalpine
    Series A